Latin America Nebulizer Market

Latin America Nebulizer Market Size (2023 to 2028)

As per our analysis report, the Latin America Nebulizer Market is forecasted to register a healthy growth rate between 2023 to 2028.

Nebulizers are primarily used to relieve extreme respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.

The increasing prevalence of chronic respiratory diseases is one of the significant factors promoting the growth rate of the Latin America nebulizer market. Busy schedules, sedentary lifestyles, and lack of physical activity have led to an increase in the prevalence of obesity across the Latin American region. This, together with the increase in the consumption of tobacco and alcohol, contributes significantly to the increase in the occurrence of respiratory disorders, thus boosting the sales of nebulizers.

Apart from this, increasing pollution levels due to the increasing adoption of private vehicles and expansion of industries is another key factor contributing to the demand for nebulizers in the Latin American region. In addition, the growth of the geriatric population has led to an increase in the demand for home care devices, which is driving the demand for portable variants. In addition, several organizations are taking initiatives to promote awareness of the treatment options available for respiratory illnesses. For example, the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) actively educates the public about the risks and treatment of COPD.

Furthermore, the Latin American nebulizer market growth is expected to accelerate owing to the growing demand for home healthcare. This allows patients to comfortably use nebulizers and medications at home. Home health care is cheaper than hospital stays, which is boosting the market. The adoption of nebulizers in-home care is increasing due to their easy availability.

Large companies in the global nebulizer market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition.

Some factors may hamper the growth of the Latin American nebulizer market such as drug loss during drug administration as well as device maintenance. The unwanted effects associated with the use of the nebulizer such as infection are likely to hamper the growth of the market. Other factors can negatively impact the market, including transportation difficulties and extra administration time.

Impact of COVID-19 on the Latin American Nebulizer Market:

The increase in COVID-19 virus infections around the world has increased the demand for nebulizers. The use of nebulizers to treat patients affected by the coronavirus is growing during the COVID-19 pandemic.

Many COVID-19 patients require hospitalization and intensive / emergency care, the demand for medical ventilators and nebulizers to help deliver drugs directly to the lungs has shown an increase in the market grew dramatically between 2020 and 2022. The situation of the COVID pandemic- 19 significantly affected Latin America. The number of people affected by COVID-19 is higher than expected; more than thousands of people are affected by the coronavirus. Large numbers of people enter emergency rooms and use ventilators and nebulizers.

The Latin America Nebulizer Market Research Report has been segmented and sub-segmented into the following categories.

By Product:

• Jet Nebulizer
• Mesh Nebulizer
• Ultrasonic Nebulizer

By Modality:

• Portable
• Table-top

By End-User:

• Hospitals
• Clinics
• Home care settings

By Country:

• Mexico
• Brazil
• Argentina
• Chile
• Rest of Latin America

Geographically, the nebulizer market in Latin America expects to grow at a healthy CAGR during the forecast period due to the rising aging population prone to chronic respiratory diseases.

The Brazilian nebulizer market is expected to lead the Latin American market contributing to significant support to this regional market due to the growing incidence of COPD diseases, T.B., Asthma, and pneumonia. As per the Unified Public Health System's Mortality Information System, in 2015, nearly 37,000 lost their lives in Brazil due to COPD. The rising funds and investments from the government healthcare field and rising technological advancements boost the Brazilian market. In May 2019, Deepro TM, the Federative Republic of Brazil, launched its new vibrating mesh nebulizer, and this has cutting-edge technology that enables an aerosol of the medications, allowing a small particle size to be inhaled deep into the lungs. 

The Mexican nebulizer market is predicted to be one of the lucrative regional markets in Latin America. The growing adoption of medical devices and increasing demand for respiratory diseases in Mexico are expected to support the Mexican market. 

KEY MARKET PLAYERS:

Companies such as Briggs Healthcare, Besco Medical, Ca-Mi, De Vilbiss Healthcare, Feellife Health, Flyp, Invacare, Omron, Philips Respironics, and Pari Medical are expected to play a significant role in the Latin American market.